Rajesh et al. [42,43] reported an increase in the expression of FAS and the membrane-bound form of Fas-L after exposing human prostate carcinoma, human glioblastoma, human astrocytoma, and rat glioma cells to POH. Here, FAS is linked to central nervous system cancer.